Long-term prazosin therapy for COPD pulmonary hypertension.
A 51-year-old patient with COPD, obesity, and pulmonary hypertension underwent long-term prazosin therapy after a successful hemodynamic response to 1 mg of oral prazosin. The 18-month administration of prazosin, in a dose of 3 mg a day, resulted in continued hemodynamic and echocardiographic benefits.
Lewczuk
J
J
Department of Cardiology and Medicine, County Hospital, Wrocław, Poland.
Sobkowicz-Woźniak
B
B
Piszko
P
P
Spikowski
J
J
Wrabec
K
K
D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D011224:Prazosin / Q000627:therapeutic use*; D012074:Remission Induction; D013997:Time Factors
D011224:Prazosin